Results 261 to 270 of about 61,480 (319)

Geranylgeranoic acid and the MAOB-CYP3A4 axis: a metabolic shift underlying age-related liver cancer risk. [PDF]

Front Aging
Tabata Y.
europepmc   +1 more source

Confounding Effect of Hepatic Carboxylesterase 1 (CES1) Variability on Clopidogrel Oxidation. [PDF]

Mol Pharm
Subash S, Singh DK, Khojasteh SC, Murray BP, Zientek MA, Jones RS, Kulkarni P, Smith BJ, Prasad B.   +8 more
europepmc   +1 more source

Association of Metabolic Genotype Composite CYP3A5*3 and CYP3A4*1B to Tacrolimus Pharmacokinetics in Stable Black and White Kidney Transplant Recipients. [PDF]

Clin Transl Sci
Brazeau D, Attwood K, Cooper LM, Gray V, Chang S, Chen S, Murray BM, Tornatore KM.   +7 more
europepmc   +1 more source

Assessment of the Intestinal CYP3A Contribution to Drug Interactions with Extended-Release Tacrolimus (LCPT) Using Grapefruit Juice. [PDF]

Clin Pharmacol Drug Dev
Alabi A, Kerr JS, Shah M, Khan A, Ma JD, Suhandynata RT, Momper JD, Tsunoda SM.   +7 more
europepmc   +1 more source

Pyrazoline B Induces Oxidative Stress Mediated Toxicity, Cell Cycle Arrest, and Caspase-Independent Apoptosis in BT-474 Human Breast Cancer Cells. [PDF]

J Exp Pharmacol
Wiraswati HL, Satriyo PB, Bashari MH, Sholikhah EN, Wahyuningsih TD, Ma'ruf IF, Yeh CT, Mustofa M.   +7 more
europepmc   +1 more source

Protein Levels of 16 Cytochrome P450s and 2 Carboxyl Esterases Using Absolute Quantitative Proteomics: CYP2C9 and CYP3A4 Are the Most Abundant Isoforms in Human Liver and Intestine, Respectively. [PDF]

Pharmaceuticals (Basel)
Grangeon A, Arwood ML, Thacker D, Gaudette F, Turgeon J, Michaud V.   +5 more
europepmc   +1 more source

Efficacy of fourteen-day once-daily vonoprazan-based quadruple therapy for Helicobacter pylori in high clarithromycin-resistance regions (ONCE-VONO Trial). [PDF]

Sci Rep
Sukkamolsantiporn S, Bongkotvirawan P, Chonprasertsuk S, Pornthisarn B, Siramolpiwat S, Bhanthumkomol P, Issariyakulkarn N, Gamnarai P, Wongcha-Um A, Aumpan N, Vilaichone V, Sornchuer P, Mahachai V, Miftahussurur M, Yamaoka Y, Kitipawong P, Vilaichone RK.   +16 more
europepmc   +1 more source

Investigation of the Relevance of CYP3A4 Inhibition on the Pharmacokinetics of the Novel P2X3 Antagonist Filapixant: Results of In Vitro Explorations and a Fixed-Sequence Clinical Trial with Itraconazole in Healthy Volunteers. [PDF]

Int J Mol Sci
Francke K, Rottmann A, Klein S, Höchel J, Friedrich C.   +4 more
europepmc   +1 more source

Pharmacological Management of Oral and Esophageal Candidiasis: A Clinical Pharmacotherapy Perspective. [PDF]

J Clin Med
Hirai T, Nashi M.
europepmc   +1 more source